Hca Healthcare Stock Short Ratio
2BH Stock | EUR 301.00 0.10 0.03% |
HCA Healthcare fundamentals help investors to digest information that contributes to HCA Healthcare's financial success or failures. It also enables traders to predict the movement of HCA Stock. The fundamental analysis module provides a way to measure HCA Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HCA Healthcare stock.
HCA |
HCA Healthcare Company Short Ratio Analysis
HCA Healthcare's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
Based on the latest financial disclosure, HCA Healthcare has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Care industry. The short ratio for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
HCA Fundamentals
Return On Equity | 0.97 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.15 % | |||
Current Valuation | 102.14 B | |||
Shares Outstanding | 276.97 M | |||
Shares Owned By Insiders | 26.03 % | |||
Shares Owned By Institutions | 66.24 % | |||
Price To Earning | 11.00 X | |||
Price To Book | 295.04 X | |||
Price To Sales | 1.07 X | |||
Revenue | 60.23 B | |||
Gross Profit | 23.18 B | |||
EBITDA | 13.29 B | |||
Net Income | 5.64 B | |||
Cash And Equivalents | 2.54 B | |||
Cash Per Share | 7.46 X | |||
Total Debt | 37.71 B | |||
Current Ratio | 1.44 X | |||
Book Value Per Share | (9.98) X | |||
Cash Flow From Operations | 8.52 B | |||
Earnings Per Share | 18.05 X | |||
Price To Earnings To Growth | 1.34 X | |||
Target Price | 271.48 | |||
Number Of Employees | 207 K | |||
Beta | 1.63 | |||
Market Capitalization | 63.39 B | |||
Total Asset | 52.44 B | |||
Z Score | 1.6 | |||
Annual Yield | 0.01 % | |||
Net Asset | 52.44 B | |||
Last Dividend Paid | 2.24 |
About HCA Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HCA Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HCA Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HCA Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in HCA Stock
HCA Healthcare financial ratios help investors to determine whether HCA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HCA with respect to the benefits of owning HCA Healthcare security.